We describe the evolution of quantitative T2 relaxometry values on serial MRI in patients with a solitary cerebral cysticercal lesion (SCCL), and determine whether albendazole therapy affects T2 relaxation (T2R) values. Patients with new-onset seizures and MRI-confirmed SCCL were randomized to treatment with albendazole and antiepileptics ("treatment group") or antiepileptics only ("controls"). Serial MRI including T2 relaxometry was performed at baseline, three, six, 12, and 24 months. Of 123 patients recruited, 81 had more than three MRI scans (treatment group: 37; controls: 44; 58 patients had five scans). The lesion wall at baseline showed a mean T2R value of 152.3 ms, centre 474.9 and perilesional parenchyma 338.5 ms. These were significantly higher than those from normal parenchyma (114 ms). Over time, most sharply in the initial three months, T2R values fell but even at 24 months, they remained above those from normal parenchyma. A slight increase in T2R values from the lesion centre at six months was thought to represent the initiation of gliosis. In the treatment group, T2R values approached normal at 24 months, while controls had persistently higher T2R values. The decline in T2R values at six months was more prominent in the treatment group. T2R values at baseline and at three months differed significantly depending on the stage of the lesion, being higher in stage 2 SCCL. T2R values from SCCL declined over 24 months, being significantly higher in earlier stages of degeneration. A mild increase after six months may be due to the initiation of gliosis. T2R values appear to decline faster in patients who receive albendazole.
Introduction
Cysticercosis is the most common parasitic disease of the central nervous system, affecting millions of individuals in both the developing countries of Asia, Africa and Latin America and in developed countries. It is caused by the encysted larval stage of the pork tapeworm Taenia solium 1 . Imaging in neurocysticercosis (NC) often shows single small ring-enhancing lesions, the diagnosis of which has always been a problem as they have to be differentiated from other ring lesions 2 . Computed tomography and magnetic resonance imaging (MRI) are useful investigations for diagnosing NC 3 , but MRI is considered the investigation of choice for studying the evolution of cyst as well as the effect of medication 4, 5 . Although the natural history of NC has been studied using serial CT and MRI 6 , newer quantitative techniques have been infrequently used to prospectively study the evolution of these lesions. Magnetization transfer imaging (MTI) has proven useful in delineating gliosis around the SCCL which is seen as a hyperintense signal barely visible on conventional T2-weighted imaging [7] [8] [9] [10] . T2 relaxometry is a magnetic resonance imaging (MRI) morphometric technique, which provides a quantitative and objective means of comparing normal and pathological relaxation characteristics 11 . Although the evolution of the cysticercal lesion on MTI has been described 10 , the corresponding changes in T2 relaxometry over time remain unknown. In addition, even though NC is generally treated with cysticidal drugs such as albendazole and praziquantel, the effect of albendazole on the evolution of the SCCL and the appearance of adjacent perilesional gliosis is unclear. The present study is part of a prospective randomized controlled trial of albendazole in a cohort of patients with SCCL and new-onset seizures. We previously reported the effect of cysticidal therapy with albendazole on the evolution of the cysticercal lesion on serial conventional MRI 6 and on MTI 10 . This paper presents the evolution of quantitative T2 relaxation (T2R) values over a period of 24 months in patients with SCCL. We also describe the effect of cysticidal therapy with albendazole on the T2R properties of these lesions.
Materials and Methods
Patients were prospectively enrolled at the National Institute of Mental Health and Neurosciences, a tertiary national referral centre for neurological diseases in India. After obtaining written informed consent, all patients presenting with new-onset focal or generalized seizures were subjected to plain and contrast CT scan of the brain followed by contrast MRI in every case. Patients were excluded from the study if they had evidence of other lesions on CT /MRI, a history of epilepsy, received albendazole or praziquantel, significant neurologic deficits, raised intracranial pressure or seizures refractory to acute treatment. Those with an MRIconfirmed solitary cysticercal lesion in the cerebral parenchyma were included in the study.
All patients were imaged using a circular polarised head coil on a 1.5T system (Magnetom Vision, Siemens, Erlangen, Germany) according to a pre-determined protocol, which included pre-and post-contrast fast spin echo (SE) T1weighted sequences ( troscopy. Imaging in the axial plane was performed using 5-mm slice thickness with an interslice gap of 0.5 mm, 24 × 24 cm field of view, and a matrix size of 256 × 256. All patients had post-gadolinium (0.1 mmol/kg) studies. T2 relaxometry were performed in all patients using a dual echo sequence (TR=5500 ms; TE=90 ms and 22 ms). The images were transferred to an installed software programme. T2 relaxometry maps were generated manually from the measured image intensities at the level of the lesion. T2 values were calculated in the cyst, perilesional parenchyma (PLP) and normal white matter (WM). Patients were imaged at least 24 hours after the last seizure. The stage of the lesion was determined based on the criteria proposed by us previously 6 . The patients were randomized to two groups by means of a random-number table consisting of 200 random numbers: one group received antiepileptic drugs only (usually phenytoin or carbamazepine/oxcarbazepine) and the second group was given albendazole 15 mg/kg/day in two divided doses for 28 days in addition to antiepileptic medication. All patients were compliant with the medication.
Repeat imaging studies following the same MRI protocol were carried out at three, six and 12 months after the first evaluation. The imaging procedures were funded by the Indian Council for Medical Research. At one month after enrolment in the study and at every followup thereafter, at the time of obtaining repeat imaging the patients were evaluated regarding recurrence of seizures, any side-effects of treatment, compliance with therapy and the presence of fresh symptoms. The antiepileptic drug was tapered and stopped at the end of a twoyear seizure-free period. Patients with more than 12 months' follow-up were included in the final analysis.
Two independent trained observers and a neuroradiologist who were blinded to treatment allocation analysed the MRI for cyst location, size, presence of scolex, extent and severity of perilesional oedema, contrast enhancement and cyst persistence, resolution or calcification and T2 relaxometry parameters on follow-up scans. The lesion was considered to have resolved when it disappeared without any evidence on pre-and post-contrast MRI.
Descriptive statistics included percentages, mean and standard deviation. The T2 relaxation parameters obtained on serial MRI over 24 months were tabulated, and the distribution of variables between the treatment and control groups was subjected to multivariate analysis to detect differences in evolution of the lesion and PLP changes attributable to albendazole. Chi-square test was used to study categorical variables, and one-way analysis of variance (ANOVA) was used for continuous variables, including the effect of the stage of the lesion on T2 relaxation values.
Results
A total of 123 patients with new-onset seizures due to SCCL were recruited, of whom 81 underwent at least four serial MRI scans with T2 relaxometry at baseline, three, six and 12 months after enrolment. Fifty-eight patients had an additional fifth MRI at 24 months after enrolment. Thirty-seven patients had received albendazole (treatment group) and 44 had not (control group). All lesions were cortical or at the cortico-subcortical junction. Demographic data are presented in Table 1 , and there was no statistically significant difference between the treatment and control groups. All cysts at enrolment were active, in stages 2 or 3 as per the classification proposed by us previously 6 .
Serial quantitative T2 relaxometry
The normal white matter had a T2 value of 114 ms in our study. The average T2 value of stage 2 lesions (corresponding to Escobar's colloid-vesicular stage) 6, 12 was 321 ms, that of stage 3 (granular nodular) lesions was 389 ms and that of stage 4 (nodular calcified) lesions was 84 ms. Normal grey matter had a slightly higher mean T2 value than white matter. The wall of the lesion on the initial MRI showed a mean T2 value of 152.3 ms, while the centre of the lesion and the perilesional parenchyma had values of 474.9 and 338.5 ms respectively. These differed significantly from normal white and grey matter. Over time, the T2 values of these regions declined significantly. On serial MRI, T2 relaxometry values in the wall declined over the first three months and then remained fairly constant, while those from the centre of the lesion and in the perilesional parenchyma showed a progressive decrease with a sharp decline in the first three months (p <0.01 for the mean T2 values on serial MRI compared to the baseline values for the wall and centre of the lesion, and p <0.001 for the mean T2 values on serial MRI compared to the baseline values for the perilesional parenchyma). The T2 values of the lesion centre and the perilesional parenchyma remained significantly higher than normal white and grey matter even 24 months after enrolment, while those of the lesion wall were similar to those of normal brain parenchyma from the second MRI onwards ( Table 2 ). Figure 1 shows a cysticercal lesion on conventional MRI and a T2-relaxometry map, while Figures 2 and 3 show serial T2R images and T2R maps in patients who received and did not receive albendazole.
Effect of albendazole therapy on T2 relaxation values
There was no significant difference between the treatment and control group in the overall T2 values from the centre of the lesion. However there was a significant difference in the decline of the T2 value between the treatment group and the control group between the third and sixth months. The T2 value of the treatment group decreased more rapidly compared to that of controls during this period, and approached the normal range, whereas that of the control group remained high. Similarly, at the 24-month scan the difference between the T2 values at the centre of the lesion showed a trend towards significance (p=0.054) with T2 values of the treatment group approaching normal whereas those of the control group continued to be high. The T2 values in the wall of the lesion showed a similar trend, but the differences between the treatment and control groups were less significant. Similarly, the T2 value of the perilesional area showed a sus-tained decrease for the first six months with a sharp fall over the first three months, but without any difference between the two groups ( Table 3) .
Effect of lesion stage on T2 values
T2R values of the lesion wall at baseline differed significantly depending on the stage of the lesion (for lesions in stage 2, mean T2R value was 161.8, while for those in stage 3 it was 134.5, p=0.029 by one-way ANOVA). Similarly, the T2R values for cyst contents and the perilesional area, and the average T2R values for the entire cyst and the area adjacent to the cyst were higher in stage 2 lesions than in stage 3 at baseline and at three months (Table 4). Lesions at stage 2 at baseline also had higher mean T2R values in the perilesional area and up to 12 months after enrolment. At six months, there was a significant difference in T2R values only in the perilesional area, but in later MRIs no difference was seen in T2R values in lesions at different stages of degeneration.
Discussion
This cohort of patients with new-onset seizures due to SCCL was subjected to serial MRI including T2 relaxometry to study the evolution of T2 relaxation values over two years. Although the diagnosis of neurocysticercosis was not histologically confirmed -patients being diagnosed based on accepted radiological crite- ria -this is within the norm for such studies as routine biopsy for a single ring-enhancing lesion is no longer considered justifiable. Patients were randomly allocated to albendazole treatment or a control group in order to evaluate the effect of anthelmintic therapy on this evolution. We demonstrated that the lesion wall, centre and PLP showed significantly higher T2R values compared to normal brain parenchyma; that these values declined over time, particularly in the initial three months; and that the T2R values differed significantly according to the stage of degeneration of the cysticercal lesion. Albendazole therapy did not significantly affect the evolution of T2R values in our cohort, although T2R values remained higher in patients who did not receive albendazole, even 24 months after enrolment. Quantitation of T2 relaxation time has been used to assess focal damage, which may not be readily apparent on conventional MRI. T2 relaxation of the central nervous system is shown in animal models to consist of distinct components corresponding to extra-axonal water protons, axonal protons, and protons possibly associated with mobile lipids in myelin sheaths 13 , T2 signal intensity is increased (reflecting a focal increase in T2 relaxation) in areas of oedema and tissue damage, where more free water is associated with relative expansion of the extracellular space 14 . On the other hand, T2 relaxation times decrease with increasing protein concentration 15 . T2 relaxometry represents an objective and sensitive way of detecting this change in T2 relaxation. In T2 relaxometry, T2 relaxation is computed from a series of MR images obtained at the same TR (time of repetition) and different echo time 13 . This technique is simple and rapid, utilizes data acquired for routine proton-density and T2W imaging, and can be implemented on standard clinical MR systems. The measurements can be easily ac-quired and are reproducible 16 . It is useful for the systematic quantitative study of patients, particularly when routine T2-weighted MRI is unremarkable 17, 18 . The method has been successfully used to evaluate patients with mesial temporal sclerosis and demyelinating disorders such as multiple sclerosis 19 . Quantitation of T2 relaxation time in tissues that appear normal to gross image inspection in patients with temporal lobe epilepsy has shown significantly higher T2 values compared to the normal tissue (around 19% increased over normal side) [20] [21] [22] . Structural changes in normal-appearing white matter (NAWM) have been demonstrated in patients with multiple sclerosis using T2 relaxometry 23 . Beta-amyloid plaque deposits in patients with Alzheimer's disease may be visualized by T2 relaxometry 24 . This technique has also been used to study patients with NCC and has shown promise in differentiating NCC from tuberculomata 18 , as well as quantifying gliosis around healing and healed cysticercal granulomata 25 .
To the best of our knowledge, there are no previous reports of either serial imaging of NCC lesions with T2 relaxometry or the T2 relaxation values of different stages of NCC. In our study, the majority of lesions were in stage 2 at the time of initial evaluation, at three and six months most were in stage 3 while at later evaluations most lesions were in stage 4 or had resolved. These radiologic stages roughly correspond to the four pathologic stages described by Escobar 6, 12 . In the vesicular stage, the cyst contains clear fluid with little or no inflammation. At this stage, the lesion is expected to show high T2 relaxation values. As there is no inflammation and gliosis at this stage, the perilesional parenchyma is expected to show normal T2 values. In our study, there were no lesions in the vesicular stage as we recruited only patients with symptomatic SCCL. Due to the lack of inflammation around a live cyst, these are generally asymptomatic 26 . In the vesicular colloid stage, the wall of the lesion thickens and the protein content of cyst fluid rises, containing abundant inflammatory cells. In the granular nodular stage, the lesion shows a further increase in the protein content with gelatinous granulomatous semisolid material in the centre of lesion. The wall of the lesion thickens further at this stage and perilesional gliosis sets in. In the nodular-calcific stage, the lesion is calcified with abundant perilesional gliosis.
As would be expected from the evolution of pathological changes in a degenerating cysticercus, lesions at the initial MRI showed high T2 relaxation values in the centre of the lesion, due to the fluid content. Jayakumar et al. found that the mean T2R value of cysticercal cysts was 617 ms (range, 305-1365) which is very similar to the value from the centre of the lesion in our cohort. They also demonstrated that T2 relaxometry reliably differentiated NCC from tuberculomata, in which the T2R values range from 83 to 290 ms. However, a wide range of T2R values was seen in their study, which was explained as resulting from the metachronic stages of cyst evolution through varied substrates of oedema and/or gliosis with resultant variations in hydration states 16 . Our cohort showed a progressive, statistically significant decline in the T2R value over time and as the lesions progressed through the various stages of degeneration. This is due to the increasing albumin and glycoprotein content of the cyst fluid and mineralization of the cyst 12, 15, [27] [28] [29] . We demonstrated a significant relation between the stage of the lesion and the T2R value, particularly when differentiating stage 2 from later stages. The T2R value was highest in stage 2 and declined as the lesion progressed to later stages. Lesions with greater values of T2 relaxation were more hyperintense on T2W images, corresponding to stage 2; the less hyperintense lesions showed lower T2 relaxation values and corresponded to the later stages of cysticercal degeneration 16 . However, even at 24 months T2R values from the lesion centre remained higher than normal brain parenchyma.
Similarly, the perilesional parenchyma showed high T2R values in the initial MRI due to perilesional oedema resulting from inflammation around the degenerating cysticercus, although vasculitis, infiltration and gliosis may also be responsible 30 . As inflammation resolved, T2R values fell over time and with progression from stage 2 to later stages. However, T2R val-ues from the PLP remained significantly higher than normal parenchyma even after oedema resolved, due to gliosis around the lesion. Increased T2 relaxation values reflect the severity of reactive gliosis due to neuronal loss 12 . In an earlier study on patients with NCC, T2R values in PLP were higher in patients with visible gliosis on MTI than those without. However, even though the T2R value increased by as much as 25%, the gliosis could not be seen on conventional T2-weighted images 25 . The lesion wall appeared relatively hypointense, and had a lower T2R value than the lesion centre or the PLP. The reason for this relative hypointensity is not known, but is thought to be due to paramagnetic substances in the cyst wall 29 .
In our patients, T2R values in the centre and wall of the lesion declined in the first three months in both the control and treatment groups. After six months, patients receiving albendazole therapy showed a T2R value approaching normal while values in the control group continued to be high, albeit reduced from the baseline. Subsequently -one year from enrolment -the T2R values increased in both groups, possibly indicating the initiation of gliosis. This increase in T2R value was more prominent in the lesion centre, suggesting that gliosis may commence at the centre of the lesion. Two years after enrolment, T2R values from the lesion centre and PLP were lower in the treatment group than in the controls, but this difference did not reach statistical significance. This may indicate an effect of albendazole therapy on the development of gliosis. In a previous paper studying the same cohort of patients, we showed that gliosis in the PLP as visualized on MTI may be influenced by treatment with albendazole, but again did not demonstrate statistical significance 10 . However, gliosis is an ongoing process and continues to form even two years after the onset of degeneration. Thus, it is foreseeable that a similar study with imaging after a longer period of follow-up will reveal more gliosis, and better conclusions may be possible.
A previous study using MTI and T2 relaxometry to evaluate the PLP in patients with NCC reported an inverse relationship between the T2R value and the magnetization transfer ratio (MTR). In patients with gliosis on MTI, highly significant differences were found between mean T2R values determined from the perilesional and normal contralateral regions. A linear regression fit analysis showed a highly significant inverse correlation between perile-sional T2 values and MT ratios 25 . In our previous paper on MTI in SCCL, the MTR from the lesion increased progressively from the baseline to the 24-month MRI 10 , and the present study confirms an inverse relation with T2R time. The highest MTR values have been reported in healing T2 hypointense lesions while vesicular lesions showed the lowest values. Intermediate values were reported in healing hyperintense lesions 31 . In view of these findings, the T2R value is expected to decrease with advancing degeneration, which was confirmed in this study. Strong correlations between T2R time and MTR have been reported in the abnormal white matter but not NAWM in the brains of patients with multiple sclerosis 32 . Significant inverse correlations were noted between T2R values and MTR (P<0.001) in tuberculomata 33, 34 .
The role of treatment with albendazole in cases of single ring-enhancing lesions continues to be controversial. Our results suggest a possible effect of such treatment on the evolution of cysticercal single ring-enhancing lesions, as we observed higher T2R values in patients who did not receive albendazole compared to those who did. However, the clinical importance of this radiological finding remains unclear as previous papers studying the same cohort demonstrated that there was no significant difference between the two groups in terms of overall seizure control 35, 36 . Further studies with longer follow-up may resolve this question.
In conclusion, T2R values from SCCL declined on serial MRI over 24 months, and were significantly higher in earlier stages of degeneration. A mild increase after six months may be due to the initiation of gliosis within the SCCL as well as in the PLP. T2R values appear to decline faster in patients who received anthelmintic therapy, but more studies involving a larger number of patients with longer follow-up will probably clearly demonstrate an effect of albendazole treatment on the T2R values from the cysticercal lesion.
